Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

CCNG1

  • Open Access
    Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers
    SANT P. CHAWLA, SAMANTHA JEFFREY, SKYLER S. PANG, ROBIN L. JONES, STEFAAN W. VAN GOOL, TIMO HUBER, JENNIFER KOSMAL, NEAL S. CHAWLA, RHEANNA CARTER, CHARLES B. SIMONE, KAMBIZ NAEL, HOWARD BRUCKNER, ANNA GATTANI, PAUL Y. SONG, FREDERICK L. HALL and ERLINDA M. GORDON
    Anticancer Research April 2026, 46 (4) 2025-2034; DOI: https://doi.org/10.21873/anticanres.18091
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire